ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Remote Clinical Trial Monitoring: CRA Success In An Era Of Autonomy

  As organizations become more skillful in training and monitoring CRAs, the latter can be empowered with greater flexibility and freedom in scheduling and travel.

• Can Your Clinical Trial Design Handle Mid-Study Changes?

  Mid-study changes are frequently inevitable, but it’s possible to reduce the downtime they create with strategic planning and technology. See how to plan for mid-study changes that mitigate downtime.

• Virtual eConsent For Decentralized Trials

  Virtual eConsent improves accessibility and compliance in decentralized trials, streamlining enrollment with a secure, user-friendly process for informed consent in remote research.

• The Agentic AI Connectors That Matter In Clinical Development

  An inside look at the architecture behind agentic AI in clinical research, including how modular agents, connectors, and MCP frameworks enable scalable, interoperable automation across complex trial ecosystems. 

• Driving Enrollment Predictability In Clinical Trial Timelines

  Missed enrollment targets cost millions—TA Scan’s benchmarking and simulation tools empower sponsors to forecast with confidence, optimize site strategy, and keep budgets on track.

• The Benefits Of Next-Generation SAAS Have Arrived

  See how life science companies are using software as a service (SaaS) to bring new benefits to study startup, data collection, and more with this short blog.

• Improving Site Efficiency With Automated Drug Resupply And Forecasting

  Interactive Response Technology (IRT) can transform site operations by replacing error-prone manual processes with real-time, automated systems that relieve some of the burden on trial sites.

• Digital Measurement Of Nocturnal Scratch In Atopic Dermatitis

  A major challenge in managing atopic dermatitis (AD) is the lack of objective tools to measure the impact of nocturnal scratching, but new digital measurement solutions could address this gap.

• Growing Pains: The Real Story Behind Gen AI Development In Clinical Trial Ops

  As Gen AI develops and reaches advanced stages it introduces risks such as model hallucinations, which can affect trial accuracy and reliability. Explore how to address these challenges.

• Increase Participant Diversity With eClinical Tools

  The right technology and community partnerships can help sponsors meet FDA diversity requirements without additional expenditures, build relationships with minorities, and prepare for future trials.